AURORA CANNABIS INC
ACB · XNASCIK 1683541fmd_1JVDZT23RZ433XT9NSJSV5BJDFManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jul 01, 2017 to Mar 31, 2025, 12 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Total revenues | 55 | 246 | 269 | 245 | 221 | 270 | 343 |
| Gross profit | 44 | 142 | (20) | (22) | 21 | 132 | 188 |
| Research and development | 2 | 15 | 26 | 11 | 10 | 4 | 4 |
| Selling, general and administrative | 72 | 258 | 287 | 175 | 175 | 143 | 154 |
| Operating income | (96) | (318) | (466) | (283) | (231) | (45) | 5 |
| Interest expense | 12 | 39 | 76 | 66 | 72 | 14 | 8 |
| Income before taxes | 77 | (331) | (3,340) | (700) | (1,720) | (58) | 20 |
| Income tax expense | 8 | (30) | (82) | (6) | (2) | (1) | 5 |
| Net income from continuing operations | 69 | (301) | (3,257) | (693) | (1,718) | (57) | 16 |
| Net income | 72 | (294) | (3,283) | (692) | (1,718) | (69) | 2 |
| Net income to common shareholders | 72 | (294) | (3,283) | (694) | (1,718) | (66) | 2 |